Juliet K. Simpson

1.1k total citations
11 papers, 400 citations indexed

About

Juliet K. Simpson is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Juliet K. Simpson has authored 11 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in Juliet K. Simpson's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Occupational exposure and asthma (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Juliet K. Simpson is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Occupational exposure and asthma (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Juliet K. Simpson collaborates with scholars based in United Kingdom, Denmark and United States. Juliet K. Simpson's co-authors include Richard P. Marshall, Toby M. Maher, Pauline T. Lukey, Diana Julie Leeming, M.A. Karsdal, Philip L. Molyneaux, Rebecca Braybrooke, Gísli Jenkins, Gauri Saini and Anne‐Marie Russell and has published in prestigious journals such as Scientific Reports, Tetrahedron and European Respiratory Journal.

In The Last Decade

Juliet K. Simpson

10 papers receiving 397 citations

Peers

Countries citing papers authored by Juliet K. Simpson

Since Specialization

Citations

This map shows the geographic impact of Juliet K. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliet K. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliet K. Simpson more than expected).

Fields of papers citing papers by Juliet K. Simpson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliet K. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliet K. Simpson. The network helps show where Juliet K. Simpson may publish in the future.

Co-authorship network of co-authors of Juliet K. Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Juliet K. Simpson. A scholar is included among the top collaborators of Juliet K. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliet K. Simpson. Juliet K. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort 2019 ·Respiratory Research ·Louise Organ, (unknown), Eunice Oballa, (unknown), Juliet K. Simpson, Arthur R Kang’ombe, Rebecca Braybrooke, Philip L. Molyneaux, Bernard V. North, (unknown), Diana Julie Leeming, M.A. Karsdal, Carmel B. Nanthakumar, William A. Fahy, Richard P. Marshall, Gísli Jenkins, Toby M. Maher	88
2	Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort 2019 ·European Respiratory Journal ·Iain Stewart, Tricia M. McKeever, Rebecca Braybrooke, Eunice Oballa, Juliet K. Simpson, Toby M. Maher, Richard P. Marshall, Pauline T. Lukey, William A. Fahy, Gísli Jenkins, Gauri Saini	4
3	Late Breaking Abstract - A PET imaging study to confirm target engagement in the lungs of patients with IPF following a single dose of a novel inhaled avß6 integrin inhibitor 2019 ·Toby M. Maher, Juliet K. Simpson, (unknown), Robert Chan, (unknown), Yi Cui, Sarah Siederer, Simon Parry, Julia Kenny, Robert J. Slack, Richard P. Marshall, Jagdeep Sahota, Gaia Rizzo, Graham E. Searle, Frederick J. Wilson, Azeem Saleem, Arthur R Kang’ombe, David Fairman, William A. Fahy, (unknown)	2
4	Using a selective avß6 PET ligand to optimise early phase IPF clinical trials 2019 ·Juliet K. Simpson, Arthur R Kang’ombe, (unknown), Frederick J. Wilson, William A. Fahy, Richard P. Marshall, (unknown), Christopher Coello, Azeem Saleem, David Fairman, (unknown), Toby M. Maher	0
5	Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis 2018 ·Scientific Reports ·(unknown), Iona Evans, David R. Pearce, Juliet K. Simpson, Toby M. Maher, Robin J. McAnulty	21
6	The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis 2018 ·Respiratory Research ·Omar S. Usmani, Martyn F. Biddiscombe, Shuying Yang, Sally Meah, Eunice Oballa, Juliet K. Simpson, William A. Fahy, Richard P. Marshall, Pauline T. Lukey, Toby M. Maher	21
7	Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants 2018 ·European Journal of Clinical Pharmacology ·(unknown), David Fairman, (unknown), (unknown), William A. Fahy, (unknown), Pauline T. Lukey, Tim Mant, Simon Parry, Juliet K. Simpson, Robert J. Slack, Stuart Kendrick, Richard P. Marshall	45
8	Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study 2015 ·The Lancet Respiratory Medicine ·Gísli Jenkins, Juliet K. Simpson, Gauri Saini, Jane H. Bentley, Anne‐Marie Russell, Rebecca Braybrooke, Philip L. Molyneaux, Tricia M. McKeever, Athol U. Wells, Aiden Flynn, Richard Hubbard, Diana Julie Leeming, Richard P. Marshall, M.A. Karsdal, Pauline T. Lukey, Toby M. Maher	198
9	Strategies for biomarker discovery in fibrotic disease 2013 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Richard P. Marshall, Juliet K. Simpson, Pauline T. Lukey	13
10	The PROFILE Study: A Prospective Study Of Fibrosis In Lung Endpoints To Discover And Qualify Biomarkers For Use In Clinical Trials 2012 ·Gauri Saini, Gísli Jenkins, Tricia M. McKeever, Juliet K. Simpson, Richard Hubbard, Simon R. Johnson, Rebecca Braybrooke, Anne‐Marie Russell, Garry Meakin, Lisa Sweeney, Helen D. Bailey, Richard P. Marshall, Pauline T. Lukey, Toby M. Maher	4
11	Base-catalyzed synthesis of bicyclic 4-aminopyrimidines from the reaction of dinitriles with mononitriles 2011 ·Tetrahedron ·Serghei Chercheja, Juliet K. Simpson, Hon Wai Lam	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact